Imperva (IMPV) Tops Q4 EPS by 5c, Q1 & FY16 Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Needham & Company Reiterates Buy Following Imperva's (IMPV) 4Q Beat and Raise
February 4, 2016 6:45 AM ESTNeedham & Company maintained a Buy rating on Imperva (NYSE: IMPV), and cut the price target to $56.00 (from $88.00), following the company's 4Q earnings report. IMPVs $72.7m and $0.20 was comfortably above $68.1m and $0.15 EPS consensus, yet investor expectations were high going into earnings. CY16 old guidance was for $285m, and last night IMPV revised... More
